Connecticut § 19a-591 Definitions.

Connecticut Statutes

§ 19a-591 — Definitions.

Connecticut § 19a-591

Title 19aPublic Health and Well-Being

Ch. 368xAIDS Testing and Medical Information

This text of Connecticut § 19a-591 (Definitions.) is published on Counsel Stack Legal Research, covering Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Conn. Gen. Stat. § 19a-591 (2026).

Text

As used in sections 19a-591 to 19a-591c, inclusive:

(1)“AIDS vaccine” means a vaccine which has been developed by a manufacturer, is being tested and administered at a research institution for purposes of determining whether it provides immunity to acquired immune deficiency syndrome or is of therapeutic benefit to persons or fetuses infected with the acquired immune deficiency syndrome virus, and for which an investigational new drug application is on file with the federal Food and Drug Administration and is in effect.

(2)“Manufacturer” means any person who is domiciled or has his principal place of business in this state and has developed an AIDS vaccine.

(3)“Research institution” means a hospital which is accredited by the Joint Commission on the Accreditation of Healthcare Organizat

Free access — add to your briefcase to read the full text and ask questions with AI

As used in sections 19a-591 to 19a-591c, inclusive: (1) “AIDS vaccine” means a vaccine which has been developed by a manufacturer, is being tested and administered at a research institution for purposes of determining whether it provides immunity to acquired immune deficiency syndrome or is of therapeutic benefit to persons or fetuses infected with the acquired immune deficiency syndrome virus, and for which an investigational new drug application is on file with the federal Food and Drug Administration and is in effect. (2) “Manufacturer” means any person who is domiciled or has his principal place of business in this state and has developed an AIDS vaccine. (3) “Research institution” means a hospital which is accredited by the Joint Commission on the Accreditation of Healthcare Organizations, or a recognized medical school which operates, or is affiliated with, or is operated by an accredited hospital. (4) “Research subject” means a person who is administered an AIDS vaccine, or a fetus of a person administered an AIDS vaccine, or a child born to a person administered an AIDS vaccine. (5) “Researcher” means a person employed by or affiliated with a manufacturer or a research institution, who participates in the development or testing or administration of an AIDS vaccine, or who is involved in the diagnosis and treatment of a research subject.